chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient began having frequent UTI's after first HPV. Then after second got yeast infections every 2 weeks and tingling in fingers and toes. After third vaccine, has worse tingling in fingers and feet fall asleep, shortness of breath with exertion, rash on face and pelvic pain.  2/16/09 PCP records received beginning 6/19/08.  Pt seen multiple times for recurring UTI's and yeast infections.  URI with asthma exacerbation 10/28/08. Returned 2/5/09 with c/o dizziness, tingling in arms and feet, SOB, R sided abdominal pressure since most recent (3rd) HPV vax.  Tingling in toes and fingers noted after 2nd vax, now up to the ankles and elbows.  Intermittant in nature. Feet feel like asleep but if attempts to stand will fall over. New onset SOB.  Becomes dizzy, releived with deep breathing. Pink area on L eyebrow appeared after #2 vax, now pink area on R chin. PE WNL. Referred to neurologist and pulmonologist.  3/25/09 Recs received from OBGYN vax provider. Normal exam 1/17/08. 1st Gardasil given. Yeast infection dx 12/11/08 on date of 3rd vax. Had sx x 3 days.
Right jaw pain; Poping, locking, chewing, opening mouth and yawning problems; Swollen gums; Swollen lymph nodes; Fatigue; Fever; Chills; Headache; Gums/blisters; This spontaneous case was reported by a consumer and describes the occurrence of GINGIVAL BLISTER (Gums/blisters), PAIN IN JAW (Right jaw pain), TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems), GINGIVITIS (Swollen gums) and LYMPHADENOPATHY (Swollen lymph nodes) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0088B21-21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced GINGIVAL BLISTER (Gums/blisters), GINGIVITIS (Swollen gums), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). On 04-Apr-2021, the patient experienced PAIN IN JAW (Right jaw pain) and TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems). On 09-Apr-2021, GINGIVAL BLISTER (Gums/blisters), GINGIVITIS (Swollen gums), LYMPHADENOPATHY (Swollen lymph nodes), FATIGUE (Fatigue), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, PAIN IN JAW (Right jaw pain) and TEMPOROMANDIBULAR JOINT SYNDROME (Poping, locking, chewing, opening mouth and yawning problems) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-245544, MOD-2021-245544 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Updated reporter information, Added patient demographics, Events were added and event outcome was updated.
Information has been received from a registered nurse concerning a 12 year old female with amoxicillin allergy and medical history of aseptic meningitis who on 17-MAY-2007 at 10:30 AM was vaccinated SC on left arm with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (Lot # 656690/0126U). It was reported that patient had received 1st dose of varicella virus vaccine live (MSD) on 26-MAY-1998. There was no concomitant medication. There was no illness at the time of vaccination. It was reported that on 18-MAY-2007 the patient developed inflamed, swollen arm 24 hours after vaccination that lasted for 2 to 3 days. No fever was reported. Unspecified medical attention was sought. At the time of report, the patient had recovered. A product quality complaint was not involved. Additional information has been received from registered nurse who stated that parents of the patient called the physician on 18-MAY-2007 and 19-MAY-2007 to report that child had developed large area of redness and swelling from shoulder to elbow. The patient was afebrile. No other symptoms were noted. The patient was not seen in the office. The patient was advised cold compresses. On 20-MAY-2007 the patient recovered. No diagnostic laboratory tests were undertaken. There was no adverse event following prior vaccination. No further information is expected.
Muscle weakness; Can not remember things; Postural instability; Disorientation; Feeling malaise; Brain fog; Imbalance while walking; getting up;  going up the stairs.; Becoming more irritable; Sick for the last 13 days; Chills; This spontaneous case was reported by a consumer and describes the occurrence of Muscle weakness, Can not remember things, Postural instability, Disorientation, and malaise in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Leukemia and Immunocompromised. Concomitant products included IMBRUVICA for Leukemia, VITAMINS for an unknown indication.    On 19-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced Muscle weakness, Can not remember things, Postural instability, Disorientation, malaise, Brain fog, Imbalance while walking, getting up, and going up the stairs, irritability, Sick for the last 13 days, and Chills. The patient was treated with TYLENOL at an unspecified dose and frequency. At the time of the report, Muscle weakness, Can not remember things, Postural instability, Disorientation, malaise, Brain fog, Imbalance while walking, getting up, and going up the stairs, irritability, Sick for the last 13 days, and Chills outcome was unknown.            Concomitant medications also included problem medicine.
Patient received vaccine 5 days earlier than recommended for 2nd dose of Pfizer COVID vaccine (day 16 vs day 21).
Patient's mother told me on 01/22/14 (our first conversation to supply me with information you need) she administered the age appropriate dose of TYLENOL to patient on the way to her appointment and 4 hours later, patient began crying and screaming upon arrival at home (approx. 10:40-10:45). No fever, but would not let mom lay her down. She finally fell asleep in mom's arms, but remained fussy that night with her daddy (mom went to work). She did not call or come by to inform our office until Dec 4, 2013.
1/26/2021 - sore arm to the point I wanted to put it in a sling to avoid ANY movement  1,18/2021 - weakness  in knees and legs, diminished sense and ability of walk and balance, somewhat feeling of ?out of it?  ALL SYMPTOMS GONE ON 1/29/2021
This case was reported in a literature article and described the occurrence of respiratory syncytial virus bronchiolitis in a subject of unspecified age and gender born between 1974 and 2008 who was vaccinated with Hib vaccine (manufacturer unspecified), Hepatitis B vaccine, Rotavirus vaccine, DTPa (small content) and IPV (non-gsk). Concurrent medical conditions included DiGeorge's syndrome and had a chromosome 22q11.2 microdeletion detected by fluorescence in situ hybridization assay. No further information on the subject's medical, family history or concurrent medication is available. On an unspecified date, the subject received an unspecified dose of Hib vaccine (administration site and route unknown, batch number not provided), an unspecified dose of Hepatitis B vaccine (administration site and route unknown, batch number not provided), an unspecified dose of Rotavirus vaccine (oral, batch number not provided), an unspecified dose of DTPa (small content) (administration site and route unknown, batch number not provided) and an unspecified dose of IPV (Non-GSK) (unknown). Less than one day after vaccination with DTPa (small content), Hepatitis B vaccine, Hib vaccine, IPV (Non-GSK) and Rotavirus vaccine, the subject experienced respiratory syncytial virus bronchiolitis and bronchospasm. The subject was hospitalised. No information has been provided regarding any examination or investigation performed on the subject. At the time of reporting the outcome of the events were unspecified. The author's conclusion stated that their data expanded the findings of smaller studies indicating that live vaccination of patients with DGS with mild-to-moderate immunosuppression was well-tolerated. Prospective studies are needed to confirm their findings and offer guidance for live vaccination. Because this study included few patients with DGS with severe immunosuppression, further retrospective investigation of this population is warranted. This case is one of the 18 cases reported in the same literature article.
Wrong vaccine administered due to incorrect selection. Patient asked after receiving her vaccine if it was Moderna and was told by by immunizer that it was Pfizer she had received. Patient waited 15 mins to make sure no side effects. 1st dose was Moderna from another pharmacy per vaccine card.
pain, redness, inflammation,  applied cold compresses,  ingested oral tylenol 1000mg
Was diagnosed with hyperthyroid 1 month after vaccine. Had miscarriage 1 month after vaccine. Had been healthy and no thyroid issue prior.
malaise, aches and pains, feels "like a cold" Caller states that she got the first vaccine ons saturday the 13th and within a couple of days starting having runny nose and sniffles, mild headache, shaking to body/hands/arms (shivering) but no fever.  Memory loss.  hypertension (pre-existing medical condition she takes medication for) and confusion.  she has alternated with APAP, ASA, ALKA-SELTZER.  she says she always gets sick from the flu vaccine.  s/s have been on/off  staff adv to f/u w/pcp.  adv s/s reported may be ameliorated with OTC analgesics taken as directed on label as well as antihistamines.  adv to call back if any questions.  someone will follow up to check on her.
Sudden episode of afib with rvr needing to go to the ER. Passing out, confusion, shortness of breath. Resolved on own approximately 2 hrs followed by extreme fatigue and headache for 2 days. Still experiencing moderate to heavy fatigue and heavy sleepiness throughout the day.
BURNING CHEST; FEVER; DIFFICULTY BREATHING; COUGHING; WHEEZING; FEELS LIKE SOMETHING IN THE BACK  THROAT; TOTAL BODY ACHES; This spontaneous report received from a consumer concerned a 65 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had unknown allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 14:15 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced difficulty breathing. On 06-APR-2021, the subject experienced coughing. On 06-APR-2021, the subject experienced wheezing. On 06-APR-2021, the subject experienced feels like something in the back throat. On 06-APR-2021, the subject experienced total body aches. On 06-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced burning chest. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning chest on 09-APR-2021, and had not recovered from difficulty breathing, coughing, wheezing, feels like something in the back throat, total body aches, and fever. This report was non-serious.
Patient (accompanied by mother) received 8 vaccines in the immunization clinic at 2:50pm. He reported mild dizziness within 3 minutes and put his head between his legs in the IZ exam room. After about 5 minutes he reported he felt better. He declined laying down on a yoga mat on the floor. I instructed him, with his mother, to sit in the waiting room for 10 more minutes before he left. The exam room was very warm and the waiting room would be cooler. He reported feeling okay when he stood up from the chair in the exam room. When we walked into the waiting room, he reported he felt dizzy. I held his arm to help him into a chair and he stumbled and then fell to the ground, slightly assisted by my arm. He did not strike his head or injure any part of his body. He appeared to lose consciousness for about 5-10 seconds and then awoke. I called for another nurse and instructed him to remain laying on the ground for 5 minutes. When he reported feeling no longer dizzy, I helped him into a chair where he sat for 15 minutes and drank juice. He left with his mother in her private vehicle after reporting no symptoms for 15 minutes.
Dizziness, Myalgia, Arthralgia, Fever, Rash, NauseaVomiting, achy jaw, congestion, arm sore, chest sore, head pressure, neck stiffness Narrative:
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. The patients concurrent conditions and medical history were not reported. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ lot # L023434, expiration date: 22-MAR-2017, orally (exact dose was not reported) (2 boxes). There were no concomitant medications provided. There were no adverse effects reported.  Administered doses of vaccines experienced the temperature excursion of 9 degrees Celsius for 120 hours. There was no previous temperature excursion. This is one of several reports received from the same reporter. Additional information is not expected as reporter refused additional contact.
This spontaneous report was received from a medical assistant referring to an unknown number of patients of unknown age and gender. The patients medical history and concurrent conditions were not provided. Since 01-NOV-2016, an unknown number of patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot number not reported. Other vaccines improperly stored included VAQTA, GARDASIL 9, M-M-R II, PEDVAX HIB and ROTATEQ. No adverse effects reported. No further information provided. This is one of several reports from the same source. Additional information is not expected.
Complaints of headache, cool to touch, "body feels weird".  Bp 140/90,  HR 78, pulseox 100%.  Recheck at 5:35  BP 128/84 , HR 77  99%puse ox.
I was sitting at my desk and I started to feel lightheaded and dizzy so I got up and walked to a recliner. I laid down there and the symptoms subsided. I stayed there for maybe half hour or so. Then about a half hour later it happened again. At that time I was standing so I laid down on the couch and it subsided. The next morning it happened one more time and I just laid down and I was ok. I called the doctor on 04/18 and got in to see the nurse practitioner later that day. They did a CBC and a chemistry blood test but I do not have the results at the moment. This happened like 2 years ago too. They did not prescribe any medications.
Vaccine given beyound 30 days of refrigeration period; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given beyound 30 days of refrigeration period) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     Concurrent medical conditions included Egg allergy, Food allergy (Plum), Drug allergy (Sulpha allergy) and Food allergy (Pepper allergy).    On 21-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given beyound 30 days of refrigeration period). On 21-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine given beyound 30 days of refrigeration period) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient other medical history includes allergy.  No concomitant medications reported by reporter No treatment medications provided by the reporter.   This case was linked to MOD-2021-313106 (Patient Link).
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-JUN-2015, the patient was vaccinated at a community care with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster, also known as shingles. On or about 01-AUG-2016, the patient was treated by a physician for onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Only the diluent portion was given; Only the diluent portion was given; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 61-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2021, the patient received Shingrix. On 15th September 2021, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The reporter reported that the patient was administrated only the diluent portion of the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. No further events were reported. The reporter agreed to follow up.
symptoms: swelling in leg, wrists, ankles; pain in joints: knees, wrist, ankles. Treatment includes prednisone for one week, followed by sulfasalazine Continue to be on sulfasalazine to reduce swelling one more 2 week course of prednisone and continuation of sulfasalazine at increased dose (2000 per day).
tested positive for Covid infection; BP: 130/68; loss of taste; loss of smell; right lower lobe pneumonia; A Spontaneous was received from a Consumer concerning a 82-years-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced right lower lobe pneumonia (Pneumonia), loss of taste (Ageusia), loss of smell (Anosmia), tested positive for Covid infection (COVID-19) and BP: 130/68 (Blood pressure abnormal).   The patient's medical history was included Chronic Obstructive Pulmonary Disease(COPD), blood pressure and Obstructive sleep Apnoea. Concomitant medications was included ATORVASTATIN CALCIUM for cholesterol, ACETYLSALICYLIC ACID for unknown indication, Advair for COPD, SALBUTAMOL for COPD, TIOTROPIUM BROMIDE for COPD and CPAP for Obstructive Sleep Apnoea.     On 22-JAN-2021 , prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch no: 013L20) via unknown route in the Left arm  for prophylaxis of COVID-19 infection.  On 03-MAR-2021, It was reported that the patient experienced loss of taste, loss of smell and BP: 130/68.  On 04 Mar 2021, the patient was tested positive for Covid infection . On 09 Mar 2021, the patient was experienced right lower lobe pneumonia. The pneumonia was medically significant.  Treatment information was Nebulizer treatment, Antibiotics for 5 days for Pneumonia and Tylenol.  Action taken with mRNA-1273 in response to the events was not reported.   On 19 Mar 2021, the outcome of the event, tested positive for Covid Infection was resolved. On an unknown date, the outcome of the events right lower lobe pneumonia, loss of taste, loss of smell, and BP: 130/68 was unknown.; Reporter's Comments: This case concerns an 82 Y/O F with a serious unexpected event of pneumonia, and nonserious unexpected COVID-19, anosmia, ageusia, and blood pressure abnormal.  Event onset 19 days after first dose mRNA-1273. Treated with antibiotics and Tylenol.  COVID-19 resolved, but other event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Mini stroke thing; Hot; 15-20 sec she had hard time talking; Mumbling; Fatigue; Chills; A spontaneous report was received from a consumer concerning his wife a 71-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue, hot/ feeling hot, chills and for 15-20 sec she had hard time talking/ dysarthria, mumbling/ speech disorder, like mini stroke thing/ transient ischaemic attack.  The patient's medical history included high blood pressure. Concomitant medications included pill for high blood pressure.  On 08 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (Batch Number: Unknown) intramuscularly in the left arm (non-dominant) for prophylaxis of COVID-19 infection. On 08 Mar 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (Batch Number: Unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 08 Mar 2021, on the same night the patient experienced felt fatigue, hot, chills and for 15-20 sec the patient had hard time talking, mumbling, like mini stroke thing a medically significant event.  No treatment information was provided.   The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  The outcome of the events, fatigue, hot, chills and for 15-20 sec she had hard time talking, mumbling, like mini stroke thing was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  The patient's medical history of high blood pressure is a risk factor for stroke and hence remains a confounder for causality. The patient did not consent for the follow up.
Information was received from a registered nurse referring to an unknown number of unspecified patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant therapy were not reported. On unspecified dates starting on or after 21-JUL-2016, the patients were administered doses of improperly stored VARIVAX injection (lot# L013826, expiration date 21-APR-2017) (dose and route unknown). The vaccines were exposed to 24.3 Fahrenheit degree (F) for 2 hours 50 minutes. There was no previous temperature excursion. Digital data logger was involved. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.